Prevest Denpro Peer Comparison

BSE: 543363

₹382.40

₹2.05 (0.54%)

As on 09-Oct-2026IST

Market cap

₹459 Cr

Revenue (TTM)

₹75 Cr

P/E Ratio

21.1

P/B Ratio

3.5

Div. Yield

0.3 %

Edit

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Market cap (₹ Cr)	459	530	50,528	16,070	7,506
Revenue (₹ Cr)	75	19	6,725	1,997	7,229
Net Profit (₹ Cr)	21.73	17.29	1,128.79	307.01	210.43
Net Margin (%)	27.10	47.19	16.02	14.56	2.88
RoE (%)	18.08	-2.13	11.51	10.63	11.02
Price to Earnings	21.13	--	44.76	51.00	35.66
Price-To-Book	3.52	0.65	4.75	5.05	3.75

Income Statement (₹ Cr)

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Operating Revenue	71.81	24.60	6,430.65	1,875.26	6,892.47
Total Income	76.72	66.85	6,746.98	2,002.19	6,963.79
Total Expenditure	46.82	26.37	4,801.11	1,436.66	6,268.09
EBITDA	24.98	-1.78	1,629.54	438.59	624.38
Depreciation	2.01	0.13	423.67	115.52	282.87
EBIT	22.98	-1.91	1,205.88	323.08	341.51
Interest	0.28	--	33.28	21.42	137.50
Other Income	4.92	42.25	316.33	126.93	71.32
Exceptional Items	--	--	-24.35	-6.80	--
Profit before Tax	27.61	95.61	1,464.58	427.47	275.33
Provision for Tax	7.12	8.60	437.26	106.74	55.72
Profit after Tax	20.49	87.02	1,027.32	320.73	219.61

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Shareholder's Funds	124.80	874.22	10,357.95	3,106.17	1,975.36
Minority Interest	--	--	--	43.07	-0.71
Non-Current Liabilities	1.25	15.96	482.17	120.16	1,225.00
Current Liabilities	7.14	2.14	1,608.40	666.53	763.90
Total Liabilities	133.19	892.32	12,448.52	3,951.60	4,084.80

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Non-Current Assets	26.70	505.88	4,921.74	1,903.19	1,820.29
Current Assets	106.49	386.44	7,526.79	2,032.74	2,143.26
Total Assets	133.19	892.32	12,448.52	3,951.60	4,084.80
Total Debt*	0.00	0.00	243.36	341.62	0.00
Net Current Assets	99.35	384.30	5,918.38	1,366.21	1,379.36
Contingent Liabilities	--	4.66	10.12	50.21	14.06

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Cash From Operating Activities	14.81	184.71	1,031.39	246.37	495.58
Cash Flow from Investing Activities	-1.59	-185.96	137.73	-225.38	-127.72
Cash from Financing Activities	-1.20	--	-416.97	20.15	-255.51
Net Cash Inflow / Outflow	12.02	-1.26	752.14	41.14	112.36

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
ROCE (%)	24.21	11.00	14.96	14.05	22.22
ROE (%)	17.79	10.01	10.56	10.94	11.93
ROA (%)	16.68	9.82	8.70	8.89	6.00
EBIT Margin (%)	41.64	164.57	30.26	30.16	10.09
Net Margin (%)	26.71	130.16	15.23	16.02	3.15
Cash Profit Margin (%)	30.44	354.32	22.56	23.12	7.19

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Revenue Growth (%)	13.93	-24.20	14.50	12.30	12.33
EBIT Growth (%)	13.22	-0.02	31.25	3.80	26.01
Net Profit Growth (%)	12.86	144.32	47.07	-5.27	46.18
EPS Growth (%)	12.86	144.32	47.07	-4.88	45.68
Book Value Growth (%)	18.21	1.23	12.70	12.14	14.76

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Price / Earnings	20.02	2.25	27.22	37.47	45.79
Price / Book Value	3.29	0.22	2.71	3.90	5.11
Dividend Yield (%)	0.29	0.00	1.18	0.29	0.00
EV/EBITDA	11.29	4.84	12.77	21.79	13.79
Market Cap (₹ Cr)	410.26	196.11	27,964.97	12,069.92	10,057.49

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Debt to Equity	0.00	0.00	0.02	0.11	0.00
Short term debt to equity ratio	--	--	--	0.08	--
Current Ratio	14.91	180.59	4.68	3.05	2.81
Quick Ratio	13.39	177.90	3.60	2.40	1.00
Interest Coverage	100.40	--	45.01	20.96	3.00

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Debtors to sales (%)	12.13	4.86	29.41	28.33	0.39
Asset Turnover	0.60	0.03	0.54	0.52	1.91
Receivable days	40.45	24.54	96.72	85.20	1.05
Inventory Days	46.74	92.65	97.32	69.58	71.25
Payable days	45.18	10.57	134.60	77.97	21.75
Cash Conversion Cycle	42.01	106.62	59.43	76.82	50.55

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.